Cdc42 and Rac1 Regulate the Interaction of IQGAP1 with β-Catenin*

Abstract

IQGAP1, a target of Cdc42 and Rac1 small GTPases, directly interacts with β-catenin and negatively regulates E-cadherin-mediated cell-cell adhesion by dissociating α-catenin from the cadherin-catenin complex in vivo (Kuroda, S., Fukata, M., Nakagawa, M., Fujii, K., Nakamura, T., Ookubo, T., Izawa, I., Nagase, T., Nomura, N., Tani, H., Shoji, I., Matsuura, Y., Yonehara, S., and Kaibuchi, K. (1998) Science 281, 832–835). Here we investigated how Cdc42 and Rac1 regulate the IQGAP1 function. IQGAP1 interacted with the amino-terminal region (amino acids 1–183) of β-catenin, which contains the α-catenin-binding domain. IQGAP1 dissociated α-catenin from the β-catenin-α-catenin complex in a dose-dependent manner in vitro. Guanosine 5′-(3-O-thio)triphosphate (GTPγS)·glutathioneS-transferase (GST)-Cdc42 and GTPγS·GST-Rac1 inhibited the binding of IQGAP1 to β-catenin in a dose-dependent manner in vitro, whereas neither GDP·GST-Cdc42, GDP·GST-Rac1, nor GTPγS·GST-RhoA did. The coexpression of dominant active Cdc42 with IQGAP1 suppressed the dissociation of α-catenin from the cadherin-catenin complex induced by the overexpression of IQGAP1 in L cells expressing E-cadherin (EL cells). Consistent with this, the overexpression of either dominant negative Cdc42 or Rac1 resulted in the reduction of E-cadherin-mediated cell adhesive activity in EL cells. These results indicate that Cdc42 and Rac1 negatively regulate the IQGAP1 function by inhibiting the interaction of IQGAP1 with β-catenin, leading to stabilization of the cadherin-catenin complex.

Footnotes

  • * This study was supported by grants-in-aid for Scientific Research from the Ministry of Education, Science, and Culture, Japan (1998), by the Japan Society of the Promotion of Science Research for the Future, by the Human Frontier Science Program, and by the grant from Kirin Brewery Co. Ltd.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • ** Present address: Dept. of Pathology, Harvard Medical School, Boston, MA 02115.

  • ¶¶ To whom correspondence should be addressed: Division of Signal Transduction, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma 630-0101, Japan. Tel.: 81-743-72-5440; Fax: 81-743-72-5449; E-mail: kaibuchi@bs.aist-nara.ac.jp.

  • Abbreviations:
    WASP

    Wiskott-Aldrich syndrome protein

    N-WASP

    Neural Wiskott-Aldrich syndrome protein

    MRCK

    Myotonic dystrophy kinase-related Cdc42-binding kinase

    GTPγS

    guanosine 5′-(3-O-thio)triphosphate

    GST

    glutathione S-transferase

    MBP

    maltose-binding protein

    aa

    amino acid

    PAGE

    polyacrylamide gel electrophoresis

    HA

    hemagglutinin

    DSP

    dithiobis(succinimidyl propionate)

    CHAPS

    (3-[(3-cholamidopropyl)dimethylammonio]propanesulfonic acid)

    IL

    interleukin

    MDCK

    Madin-Darby canine kidney

    GDI

    GDP dissociation inhibitor

    • Received March 2, 1999.
    • Revision received May 25, 1999.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement